# EDGAR Filing Document

**Accession Number:** 0000883984
**File Stem:** 0001193125-25-176982
**Filing Date:** 2025-8
**Character Count:** 17208
**Document Hash:** 5ea935ea04f7f43eff416532c682beb5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-176982.hdr.sgml**: 20250808

**ACCESSION NUMBER**: 0001193125-25-176982

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 16

**FILED AS OF DATE**: 20250808

**DATE AS OF CHANGE**: 20250808

**EFFECTIVENESS DATE**: 20250808

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ICU MEDICAL INC/DE
- **CENTRAL INDEX KEY:** 0000883984
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 330022692
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-289419
- **FILM NUMBER:** 251198382

**BUSINESS ADDRESS:**
- **STREET 1:** 951 CALLE AMANECER
- **CITY:** SAN CLEMENTE
- **STATE:** CA
- **ZIP:** 92763-6212
- **BUSINESS PHONE:** 949-366-2183

**MAIL ADDRESS:**
- **STREET 1:** 951 CALLE AMANECER
- **CITY:** SAN CLEMENTE
- **STATE:** CA
- **ZIP:** 92763-6212

**As filed with the Securities and Exchange Commission on August 8, 2025** 

**Registration No. 333-** 

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM S-8**

**REGISTRATION STATEMENT** 

***UNDER***

***THE SECURITIES ACT OF 1933***

## ICU MEDICAL, INC.
**(Exact name of registrant as specified in its charter)** 

---

| | |
|:---|:---|
| **Delaware** | **33-0022692** |
| **(State or other jurisdiction of<br>incorporation or organization)** | **(I.R.S. Employer<br>Identification No.)** |
| **951 Calle Amanecer<br>San Clemente, California** | **92673** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**Amended and Restated ICU Medical, Inc. 2011 Stock Incentive Plan** 

**(Full title of the Plan)** 

**Brian M. Bonnell** 

**Chief Financial Officer** 

**ICU Medical, Inc.** 

**951 Calle Amanecer** 

**San Clemente, California 92673** 

**(Name and address of agent for service)** 

**(949) 366-2183**

**(Telephone number, including area code, of agent for service)** 

***Copy to:***

**Daniel E. Rees** 

**Latham & Watkins LLP** 

**650 Town Center Drive, 20th Floor** 

**Costa Mesa, California 92626** 

**(714) 540-1235**

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

------

**EXPLANATORY NOTE** 

This Registration Statement on Form S-8 (the "Registration Statement") is filed by ICU Medical, Inc. (the "Company") relating to the registration of 2,150,000 shares of the Company's common stock, par value $0.10 per share (the "Common Stock"), that may become issuable under the Third Amendment (the "Third Amendment") to the Company's Amended and Restated 2011 Stock Incentive Plan (the "2011 Plan" and as amended by the Third Amendment, the "Plan"). The Third Amendment was approved by the Company's stockholders at the Company's 2025 annual meeting of stockholders on May 13, 2025. The additional shares registered pursuant to the Plan are of the same class as other securities relating to the 2011 Plan, for which registration statements of the Company on Form S-8 (File Nos. [333-270546](http://www.sec.gov/Archives/edgar/data/883984/000119312523070695/d459729ds8.htm), [333-219106](http://www.sec.gov/Archives/edgar/data/883984/000088398417000038/s-8.htm) and [333-198256)](http://www.sec.gov/Archives/edgar/data/883984/000088398414000057/s-8registershares2011and20.htm) are effective.

Pursuant to General Instruction E of Form S-8, the contents of the above-referenced registration statements are incorporated into this Registration Statement by reference to the extent not modified or superseded hereby or by any subsequently filed document, which is incorporated by reference herein or therein.

**Item 8. Exhibits.** 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Exhibit <br>Number** | **Exhibit Description** | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | **Filed<br>Herewith** |
| **Exhibit <br>Number** | **Exhibit Description** | **Form** | **Date** | **Number** | **Filed<br>Herewith** |
| &nbsp;&nbsp;&nbsp;&nbsp;4.1 | [Certificate of Incorporation of ICU Medical, Inc., as amended and restated](http://www.sec.gov/Archives/edgar/data/883984/000088398414000046/exhibitamendedandrestatedc.htm) | 8-K | 06/10/2014 | 3.1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;4.2 | [Bylaws of ICU Medical, Inc., as amended and restated](http://www.sec.gov/Archives/edgar/data/883984/000088398423000034/exhibit31_8-k103023.htm) | 8-K | 11/03/2023 | 3.1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;5.1 | [Opinion of Latham & Watkins LLP](d908198dex51.htm) |  |  |  | X |
| 23.1 | [Consent of Latham & Watkins LLP (included in Exhibit 5.1)](d908198dex51.htm) |  |  |  | X |
| 23.2 | [Consent of Deloitte & Touche LLP, independent registered public accounting firm for the Company](d908198dex232.htm) |  |  |  | X |
| 24.1 | [Power of Attorney (included on signature page)](d908198ds8.htm#sig) |  |  |  | X |
| 99.1 | [Amended and Restated ICU Medical, Inc. 2011 Stock Incentive Plan](http://www.sec.gov/Archives/edgar/data/883984/000088398423000009/exhibit106amendedandrestat.htm) | 10-K | 02/27/2023 | 10.6 |  |
| 99.2 | [First Amendment to ICU Medical, Inc. Amended and Restated 2011 Stock Incentive Plan](http://www.sec.gov/Archives/edgar/data/883984/000088398420000014/exhibit1012firstamendm.htm) | 10-K | 03/02/2020 | 10.12 |  |
| 99.3 | [Second Amendment to ICU Medical, Inc. Amended and Restated 2011 Stock Incentive Plan](http://www.sec.gov/Archives/edgar/data/883984/000088398423000024/exhibit101_8-k51723.htm) | 8-K | 05/22/2023 | 10.1 |  |
| 99.4 | [Third Amendment to ICU Medical, Inc. Amended and Restated 2011 Stock Incentive Plan](http://www.sec.gov/Archives/edgar/data/883984/000088398425000018/a8-k51325exhibit101.htm) | 8-K | 05/14/2025 | 10.1 |  |
| 99.5 | [Form of Amended and Restated 2011 Stock Incentive Plan Restricted Stock Unit Award Agreement](http://www.sec.gov/Archives/edgar/data/883984/000119312523070695/d459729dex994.htm) | S-8 | 03/15/2023 | 99.4 |  |
| 99.6 | [Form of Amended and Restated 2011 Stock Incentive Plan Performance Restricted Stock Unit Award Agreement](http://www.sec.gov/Archives/edgar/data/883984/000119312523070695/d459729dex995.htm) | S-8 | 03/15/2023 | 99.5 |  |
| 107 | [Filing Fee Table](d908198dexfilingfees.htm) |  |  |  | X |

---

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Clemente, State of California, on this 8th day of August 2025.

---

| | |
|:---|:---|
| **ICU MEDICAL, INC.** | **ICU MEDICAL, INC.** |
| By: | /s/ Brian M. Bonnell |
|  | Brian M. Bonnell <br>Chief Financial Officer |

---

------

**POWER OF ATTORNEY** 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint Vivek Jain, Brian M. Bonnell and Virginia Sanzone, and each of them, with full power of substitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act for him or her in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file this registration statement, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in order to effectuate the same as fully, to all intents and purposes, as they or he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Vivek Jain<br> Vivek Jain | Chairman of the Board and Chief Executive Officer <br>(Principal Executive Officer) | August 8, 2025 |
| /s/ Brian M. Bonnell<br> Brian M. Bonnell | Chief Financial Officer <br>(Principal Financial Officer and Principal Accounting Officer) | August 8, 2025 |
| /s/ Elisha W. Finney<br> Elisha W. Finney | Director | August 8, 2025 |
| /s/ Donald M. Abbey<br> Donald M. Abbey | Director | August 8, 2025 |
| /s/ David F. Hoffmeister<br> David F. Hoffmeister | Director | August 8, 2025 |
| /s/ David C. Greenberg<br> David C. Greenberg | Director | August 8, 2025 |
| /s/ Laurie Hernandez<br> Laurie Hernandez | Director | August 8, 2025 |
| /s/ Kolleen T. Kennedy<br> Kolleen T. Kennedy | Director | August 8, 2025 |

---

## Exhibit 5.1

**Exhibit 5.1** 

---

| | | |
|:---|:---|:---|
|  | 650 Town Center Drive, 20th Floor | 650 Town Center Drive, 20th Floor |
|  | Costa Mesa, California 92626-1925 | Costa Mesa, California 92626-1925 |
|  | Tel: +1.714.540.1235 Fax: +1.714.755.8290 | Tel: +1.714.540.1235 Fax: +1.714.755.8290 |
|  | www.lw.com | www.lw.com |
| ![LOGO](g908198g0719021215689.jpg) | FIRM / AFFILIATE OFFICES | FIRM / AFFILIATE OFFICES |
| ![LOGO](g908198g0719021215689.jpg) | Austin | Milan |
|  | Beijing | Munich |
|  | Boston | New York |
|  | Brussels | Orange County |
|  | Century City | Paris |
|  | Chicago | Riyadh |
|  | Dubai | San Diego |
| August 8, 2025 | Düsseldorf | San Francisco |
|  | Frankfurt | Seoul |
|  | Hamburg | Silicon Valley |
|  | Hong Kong | Singapore |
|  | Houston | Tel Aviv |
|  | London | Tokyo |
|  | Los Angeles | Washington, D.C. |
|  | Madrid |  |

---

ICU Medical, Inc.

951 Calle Amanecer

San Clemente, California 92673

---

| | |
|:---|:---|
| Re: | <u>Registration Statement on Form S-8; 2,150,000 shares of common stock, par value $0.10 per share.</u>  |

---

To the addressee set forth above:

We have acted as special counsel to ICU Medical, Inc., a Delaware corporation (the "<u>Company</u>"), in connection with the registration by the Company of an aggregate of 2,150,000 shares of its common stock, $0.10 par value per share (the "<u>Shares</u>"), which may become issuable under the Amended and Restated ICU Medical, Inc. 2011 Stock Incentive Plan (as amended, the "<u>Plan</u>"). The Shares are included in a registration statement on Form S-8 under the Securities Act of 1933, as amended (the "<u>Act</u>"), filed with the Securities and Exchange Commission (the "<u>Commission</u>") on August 8, 2025 (the "<u>Registration Statement</u>"). This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or related prospectus, other than as expressly stated herein with respect to the issue of the Shares.

As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the General Corporation Law of the State of Delaware (the "<u>DGCL</u>"), and we express no opinion with respect to any other laws.

Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof, when the Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the recipients thereof, and have been issued by the Company for legal consideration in excess of par value in the circumstances contemplated by the Plan, and assuming in each case that the individual issuances, grants or awards under the Plan are duly authorized by all necessary corporate action and duly issued, granted or awarded and

------

**August 8, 2025** 

**Page 2**![LOGO](g908198g0719014905908.jpg)

exercised in accordance with the requirements of law and the Plan (and the agreements and awards duly adopted thereunder and in accordance therewith), the issuance and sale of the Shares will have been duly authorized by all necessary corporate action of the Company, and the Shares will be validly issued, fully paid and nonassessable. In rendering the foregoing opinion, we have assumed that the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the DGCL.

This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act. We consent to your filing this opinion as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.

---

| |
|:---|
| Sincerely, |
| /s/ Latham & Watkins LLP |

---

## Exhibit 23.2

**Exhibit 23.2** 

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM** 

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our reports dated February 27, 2025 relating to the financial statements of ICU Medical, Inc. and the effectiveness of ICU Medical, Inc.'s internal control over financial reporting, appearing in the Annual Report on Form 10-K of ICU Medical, Inc. for the year ended December 31, 2024.

/s/ DELOITTE & TOUCHE LLP

Costa Mesa, California

August 8, 2025

## Ex-Filing

?xml version='1.0' encoding='ASCII'? EX-FILING FEES

---

| |
|:---|
| **Calculation of Filing Fee Tables**  |
| &nbsp;&nbsp;&nbsp;&nbsp;**S-8**  |
| &nbsp;&nbsp;&nbsp;&nbsp;**ICU MEDICAL INC/DE**  |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Security Type**  | **Security Class Title**  | **Fee Calculation Rule**  | **Amount Registered**  | **Proposed Maximum Offering Price Per Unit**  | **Maximum Aggregate Offering Price**  | **Fee Rate**  | **Amount of Registration Fee**  |
| 1 | Equity | Common stock, $0.10 par value per share | Other | 2150000 | $126.11 | $271136500.00 | 0.0001531 | $41511.00 |
| Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: |  | $271136500.00  |  | $41511.00  |
| Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  |  |  |  | $0.00  |
| Net Fee Due:  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  |  |  |  | $41511.00  |

---

 **Offering Note** <br>

<sup>1</sup> (1) Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall also cover any additional shares of common stock, par value $0.10 per share ("Common Stock"), of ICU Medical, Inc. (the "Company") that may become issuable under the Amended and Restated ICU Medical, Inc. 2011 Stock Incentive Plan (as amended, the "Plan") by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Common Stock. To the extent that any shares covered by an award under the Plan are forfeited, canceled or expire, such shares of Common Stock will be available for issuance under the Plan. (2) Represents an aggregate of 2,150,000 shares of Common Stock that became issuable under the Plan pursuant to the Third Amendment (the "Third Amendment") to the Plan. (3) Estimated solely for purposes of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act and based upon the average of the high and low prices of the Common Stock as reported on The Nasdaq Stock Market LLC on August 1, 2025.

---

| | |
|:---|:---|
| | |
| **Rule 457(p)** | **Rule 457(p)** |
| Fee Offset Claims | N/A |
| Fee Offset Sources | N/A |

---